Monitoring the cholesterol level is of great importance, especially for people with high risk of developing heart disease. Here we report on reagentless cholesterol detection in human plasma with a novel single-enzyme, membrane-free, self-powered biosensor, in which both cathodic and anodic bioelectrocatalytic reactions are powered by the same substrate. Cholesterol oxidase was immobilised in a sol-gel matrix on both the cathode and the anode. Hydrogen peroxide, a product of the enzymatic conversion of cholesterol, was electrocatalytically reduced, by the use of Prussian blue, at the cathode. In parallel, cholesterol oxidation catalysed by mediated cholesterol oxidase occurred at the anode. The analytical performance was assessed for both electrode systems separately. The combination of the two electrodes, formed on high surface-area carbon cloth electrodes, resulted in a self-powered biosensor with enhanced sensitivity (26.0 mA M -1 cm -2 ), compared to either of the two individual electrodes, and a dynamic range up to 4.1 mM cholesterol.
INTRODUCTION
The determination of blood cholesterol is required for the assessment of atherosclerosis and other lipid-related disorders and for estimation of the risk of thrombosis and myocardial infarction 1 .
Normal concentration of total cholesterol in blood should be less than 5.17 mM, the value can vary from person to person and depends on age, weight and gender. The borderline high level for total cholesterol concentration in human blood is defined as 5.17 -6.18 mM (typically corresponding to about 2 mM free cholesterol); the high level is defined as above 6.21 mM 2 . Thus, a highly sensitive cholesterol determination to differentiate these levels is very important for medical diagnostics.
Most of the commonly used techniques for free (~ 30%) 3 Testers" by AccuTech, LLC, USA (US Pat. № 5340539) 4 .
Most of the current biosensors use cholesterol oxidase (ChOx), which specifically catalyses the oxidation of cholesterol by molecular oxygen to 4-cholesten-3-one and hydrogen peroxide.
Different design strategies have been utilised for the development of electrochemical cholesterol biosensors including oxidation by mediated ChOx [5] [6] [7] [8] [9] [10] or hydrogen peroxide monitoring by horse radish peroxidase 11, 12 or by inorganic catalysts 13 and nanostructures [14] [15] [16] . Despite of the variety of reported cholesterol electrochemical biosensors 4 , only few of them have been shown to operate in whole blood [17] [18] [19] . An amperometric biosensor based on ChOx entrapped inside a composite polypyrrole-hydrogel membrane showed excellent correlation with results obtained by the standard method 17 for total cholesterol determination in cholesterol esterase (ChEt) pretreated serum samples. Kumar 25 , cyanide 26 and mercury ion 27 . A self-powered sensor for ascorbic acid has been developed with Prussian blue (PB) as an electrochromic display 28 . A selfcharging supercapacitor based on mediated glucose oxidase has also been reported recently 29 . To the best of our knowledge there is no research published on a self-powered cholesterol biosensor.
Despite the mentioned advantages with self-powered electrochemical biosensors, many previous devices suffered from a drawback: the use of two enzymes. This increases the cost. Also enzymes might have different optimum conditions 30 . These issues could be overcome by employing the same biocatalyst for both the anodic and the cathodic reactions driven by the same substrate, hence potentially improving efficiency and cost. There is only one report of a biofuel cell powered by the same substrate 31 . The anodic reaction was based on mediated GOx, whereas the cathodic 5 reaction exploited GOx with peroxide transduction by co-immobilised horseradish peroxidase.
This configuration still requires two enzymes.
Here we report a novel concept of a single-enzyme, membrane-free, self-powered biosensor employed for electrochemical biosensing of free cholesterol. Firstly, hydrogen peroxide generation as a result of cholesterol conversion by ChOx was monitored by electrocatalytic reduction on a Prussian Blue (PB)-modified electrode. The second electrocatalytic reaction involved cholesterol oxidation resulting from electron transfer between the enzyme active site and an electrode mediated with phenothiazine (PTZ). Both electrode reactions were achieved with ChOx attached to the electrode surface by the same immobilisation procedure: enzyme entrapment within the bulk of a sol-gel membrane deposited from media with high content of organic solvent 32, 33 . The combination of both electrochemical reduction and oxidation processes led to a membrane-free, self-powered cholesterol biosensor for whole plasma analysis, which showed enhanced analytical performance compared to the single working electrode counterparts.
EXPERIMENTAL SECTION

Chemicals
All inorganic salts, 2-propanol (anhydrous, 99.5 %), phenothiazine, Triton X-100 and γ-aminopropyltriethoxysiloxane (APTES) were obtained at the highest purity from Sigma Aldrich Cholesterol is sparingly soluble in aqueous solutions. There are many different procedures for the preparation of a homogeneous cholesterol solution described in the literature. We used the method described by Vidal et al. 34 : a stock solution of 15 mM cholesterol was prepared in phosphate buffer (50 mM, pH 6.8) with 0.1 M KCl as a supporting electrolyte containing 15% (w/w) of Triton 6 X-100 in a thermostated bath at 65 • C. This solution was stored at 4 • C in the dark and was stable for at least 10-15 days (when turbidity was observed). More dilute working solutions of cholesterol were prepared by dilution of the stock solution using a 50 mM phosphate buffer solution containing 1 % (w/w) of Triton X-100.
Blood samples were obtained from healthy donors at the local blood-bank (Blodtappen Linköping, Sweden). The samples, collected in heparin tubes, where used fresh or stored frozen at -80 °C until use.
Apparatus
An Autolab type III potentiostat (Autolab, EcoChemie, Netherlands) and an EmStat USB potentiostat (Palm Instruments, Netherlands) were employed for voltammetric and amperometric
measurements. An Ag/AgCl electrode in 3 M KCl and a platinum wire were used as reference electrode and counter electrode, respectively.
The screen-printed electrode (SPE) system with a graphite working electrode (diameter 1.9 mm), a graphite auxiliary electrode, and a Ag/AgCl pseudo-reference electrode were purchased from Rusens LTD (Moscow, Russia).
A carbon cloth electrode (CCE, specific surface of ca. 10 m 2 g -1 , resistivity of ca. 0.04  cm, the pyrographite overweight was 10%) 35, 36 from Electrougli NIPT of Carbon Wares (Russia) was used as a working electrode (geometrical surface area of ca. 0.2 cm 2 ) in the self-powered biosensor configuration.
A Rotina 380 R (Andreas Hettich GmbH & Co.KG) centrifuge was used for plasma preparation.
Cholesterol measurements in plasma were compared with those obtained using the commercially available BioVision Cholesterol/Cholesteryl Ester Quantitation Kit II, based on a spectroscopic detection of the product of enzymatic oxidation of cholesterol at 450 nm. An ELx800 Absorbance
Microplate Reader (Bio-Tek) was used for the spectroscopic detection of cholesterol.
Construction of PB-based modified electrodes 7
The SPE and the CCE were modified with PB films by chemical deposition as described 
Construction of the cathode (ChOx-PB-modified electrodes)
The ChOx-PB-modified electrodes ( 
Construction of the anode (PTZ-ChOx-modified electrodes)
The PTZ-ChOx-modified SPE and CCE ( Fig. 2A) were constructed as described previously 38 . 15
μL of an aqueous solution of the ChOx was suspended in 75 μL of an isopropanol solution of 1% APTES containing 5 mM PTZ. The resulting mixture (2 μL) was dropped on the surface of the working electrode and dried in a refrigerator (4 °C). The biosensor response was assayed in 50 mM PBS (pH 6.8).
Self-powered detection of cholesterol 8
A self-powered cholesterol biosensor was developed by combining the ChOx-PB-modified CCE as cathode with the PTZ-ChOx-modified CCE as anode. Open circuit potentials were obtained in 50 mM PBS (pH 6.8) before and after additions of the cholesterol solution. The polarisation curves were taken from 0 V to open circuit potential with a scan rate of 1 mV s -1 .
Real sample analysis
For cholesterol measurements platelet poor plasma (PPP) was prepared from human whole blood collected from 5 apparently healthy, consenting blood donors at Linkoping University Hospital.
The blood was centrifuged for 20 min at 480 g. Then the plasma was collected in new tubes.
Measurements of free cholesterol were carried out in sheer plasma by the standard addition method, by the ChOx-PB-modified electrode and PTZ-ChOx-modified screen-printed electrodes and by the self-powered biosensor.
RESULTS AND DISCUSSION
Performance study of the self-powered biosensor counterparts: cathode reaction electrode. An increase in the reduction current was observed due to the generation of hydrogen peroxide as an enzymatic reaction product being reduced by the electrocatalyst (PB). The current increased in absolute value immediately after the addition of cholesterol and rapidly reached a steady value. The average time required to reach 90% of the saturation current value was less than 20 s. The concentration of Triton X-100 increased continuously upon successive additions of the cholesterol stock solution; this consequently caused a decrease in the response 39 .
The calibration curve (Fig. 1C) shows the dependence of the response on the cholesterol concentration in the range of 0.05 -0.80 mM (R = 0.9903) with a limit of detection of 3.7 ± 0.2 μM (calculated as 3×SD/sensitivity, where SD is the standard deviation of the baseline current).
The sensitivity assessed from the linear range of the calibration curve was 20. The calibration curve was plotted in double reciprocal coordinates (Inset to Fig. 1 C) according to the electrochemical version of the Lineweaver-Burk equation 40 :
where Iss is the steady-state current after the addition of the substrate, C is the substrate bulk concentration and Imax is the maximum current measured under saturated substrate conditions. The apparent Michaelis-Menten constant Km (app), an essential parameter to describe the enzymesubstrate kinetics of the biosensor, was calculated from eq. (1). The Km (app) value was 0.76 mM, which is smaller than the values reported for ChOx immobilised into a sol-gel derived nanostructured cerium oxide matrix (2.08 mM) 41 and for free ChOx (3.9 mM) 6 ; this result illustrates the absence of diffusion limitation for the substrate by the sol-gel matrix. Ideally, for fuel cell operation the substrate should be available at concentrations well above Km (app) 30 . Thus, the developed cathode shows a Km (app) value that is compatible with those required for the selfpowered biosensor to operate in biological fluids.
Performance study of the self-powered biosensor counterparts: anode reaction The apparent Michaelis-Menten constant Km (app) for the cholesterol oxidation (Inset to Fig. 2C) was 0.14 mM. It is a lower value than those of previously reported reagentless cholesterol biosensors based on mediated ChOx 9, 6, 7 . The elaborated anode possessed a Km (app) value suitable for construction of a self-powered biosensor for blood analysis.
Performance study of the self-powered biosensor counterparts: interferences
The influences of some possible interfering compounds on the cathodic and anodic current responses to cholesterol were investigated. The amperometric responses to cholesterol (0.1 mM and 0.25 mM in cathodic and anodic systems respectively) in the presence of 0.5 mM ascorbic acid, 0.5 mM uric acid, 5 mM glucose and 2 mM lactic acid, which are possible interferences in the determination of cholesterol in blood, were measured and compared. (Fig. S1 ). In spite of the high interferent-to-cholesterol concentration ratios, no significant interference (significance level 5%) with either the cathodic or anodic processes was observed.
Self-powered cholesterol biosensor
The developed cathodic and anodic electrode systems deliver a power output proportional to the cholesterol concentration. Thus, the current passing between a shorted or resistance-circuited cathode and anode is an analytical signal, which could be measured by a simple instrument, such as a multimeter. Combination of the two developed systems allowed us to construct a one-compartment single-enzyme based biofuel cell with anode and cathode powered by the same substrate.
The measurements with standard SPEs modified with ChOx in a fuel cell-type configuration did not show current values useful for reliable registration (data not shown). In order to achieve higher signal output, filament CCEs of high surface area were used for the fabrication of both ChOxmodified cathode and anode.
The analytical characteristics of the filament CCE-based enzyme electrodes, as separate counterparts of a self-powered biosensor, towards cholesterol quantification ( Fig. S2 and S3) showed sensitivities (estimated from the linear parts of the calibration curves) of 19.4 ± 0.5 mA M -1 cm -2 and 13.8 ± 0.7 mA M -1 cm -2 for the cathode and anode systems, respectively. Both open circuit potential and power density of the cell correlated with cholesterol concentrations (Fig. S4) . However, short circuit current measurements, offering a rapid response and easy operation, were used for the studies of the concentration dependence (Fig. 4A) . gives almost two times smaller current density than anode and is located in close vicinity to the anode, allowing the involvement of the anode-leaked peroxide into the electrode reaction, decrease of the anode efficiency will probably not influence the performance significantly.
In contrast to the instability of the self-charging biosupercapacitor reported recently by Shleev et al. 29 operating in galvanostatic charge-discharge mode, only a minor steady-state current instability was observed for the cholesterol self-powered biosensor, which probably illustrates the favorable measurement mode for this type of analytical devices based on enzyme-modified filament electrodes.
The calibration plot of the short circuit amperometric responses (Fig. 4B) formed as a side product of the anodic reaction. The biocatalyst-based substrate selectivity of both counterparts allows cell operation in a membrane-free configuration, which maximises the power output as an analytical signal available for simple instrument measurements. The current densities obtained are high enough to power electrochromic display 28 . Thus, the developed approach could be used in further development of fully integrated analytical devices for personal remote monitoring.
Real sample analysis
Due to the background response instability during long-term amperometry in plasma, the current transients recorded on both SPE and filament CCE after 30 s, which corresponds to almost steadystate values, were used as analytical response (for model solutions, see Fig. S5 ). The sensitivities obtained in model solution with SPE-based cathode and anode were 8.8 ± 0.6 mA M -1 cm -2 and 12.2 ± 0.8 mA M -1 cm -2 , respectively, which is lower than obtained for the amperometry measurements, probably due to higher contribution from non-Faradic processes at shorter times.
Utilising this measurement mode, the upper level of the dynamic range for cholesterol determination was increased allowing measurements in undiluted human plasma.
The cholesterol concentrations in plasma were measured by the standard addition method ( The high specificity of detection due to the biocatalyst involvement at both electrocatalytic electrodes and to optimised operational conditions allowed reagenteless electrochemical measurements of free cholesterol in plasma, which correlated well with the standard method.
The electrical simplicity (minimal signal processing) of this approach could be extremely useful in a fully-integrated analytical device for personal cholesterol monitoring exploiting silicon-free printed electronics 20 .
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